Sort
39,280 grants matching “leukemia”
Stanford University NCTN- Network Lead Academic Site
$576,471Heather Ann Wakelee · Stanford University · U10 · FY2014 · CA
ITIM-receptors for cancer treatment
$576,447Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2021 · CA
Using the Preimplantation Factor (PIF) to Treat Graft-versus-Host Disease
$576,445Asaf Alimardanov · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Molecular Genetics of CLL
$576,406Carlo M Croce · University Of California, San Diego · P01 · FY2009 · CA
Project 1: Effects of inflammation on clonal competition and malignant transformation
$576,281Katherine Yudeh King · Baylor College Of Medicine · P01 · FY2023 · CA
Specific Adoptive Immunotherapy of Leukemia
$576,225Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2008 · CA
Lentiviral Gene Therapy and Genome Editing for X-linked Severe Combined Immunodeficiency
$576,217Stephen Gottschalk · St. Jude Children'S Research Hospital · P01 · FY2020 · HL
Lentiviral Gene Therapy and Genome Editing for X-linked Severe Combined Immunodeficiency
$576,217Stephen Gottschalk · St. Jude Children'S Research Hospital · P01 · FY2022 · HL
Lentiviral Gene Therapy and Genome Editing for X-linked Severe Combined Immunodeficiency
$576,217Stephen Gottschalk · St. Jude Children'S Research Hospital · P01 · FY2021 · HL
GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA
$576,213Nicola J Camp · University Of Utah · R01 · FY2010 · CA
Single Cell Methods for Bioeffector Discovery and Analysis
$576,206Brian O Bachmann · Vanderbilt University · R01 · FY2023 · CA
Heartland Cancer Research CCOP
$576,180Alan P Lyss · Missouri Baptist Medical Center · U10 · FY2009 · CA
Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype
$576,165Derek L Stirewalt · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
Ezh2-mediated Epigenetic Effects and Alloimmunity
$576,162Yi Zhang · Temple Univ Of The Commonwealth · R01 · FY2019 · HL
Genetic Consequences of Therapies for Cancer
$575,969John Dunning Boice · Vanderbilt University · R01 · FY2008 · CA
BIOINFORMATICS SHARED RESOURCE
$575,740Jennifer S. Shoemaker · Duke University · P30 · FY2009 · CA
Determining the Role and Targeting potential of Serine Metabolism in aggressive sub-types of Acute Myeloid Leukemia
$575,727Stephen Matthew Sykes · Washington University · R01 · FY2023 · CA
Quality of Life of African American Cancer Survivors
$575,644University Of Illinois At Chicago · R01 · FY2003 · CA
Stem Cells, Differentiation and Therapeutic Resistance in AML
$575,611Martin Carroll · University Of Pennsylvania · R01 · FY2014 · CA
Collaborative Pathways that Lead to Leukemia
$575,510Peter Aplan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
$575,510Peter Aplan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Mutation Mechanisms Leading to Malignant Transformation, Including Chromosomal Translocation and Point Mutations
$575,510Peter Aplan · Division Of Clinical Sciences - Nci · ZIA · FY2025 · CA
A rapid spontaneous murine model of CN-AML
$575,500H Leighton Grimes · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · CA
Translational Pathology Core
$575,479Sue Ellen Martin · University Of Southern California · P30 · FY2022 · CA
Improving risk allocation and developing novel therapies for children with T-ALL
$575,456David T. Teachey · Children'S Hosp Of Philadelphia · R01 · FY2019 · CA